Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for gestational diabetes
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on gestational diabetes or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on gestational diabetes and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via email@example.com
A comparison of glyburide and insulin in women with gestationaldiabetesmellitus. 11036118 2000 10 19 2000 10 19 2013 11 21 0028-4793 343 16 2000 Oct 19 The New England journal of medicine N. Engl. J. Med. A comparison of glyburide and insulin in women with gestationaldiabetesmellitus. 1134-8 Women with gestationaldiabetesmellitus are rarely treated with a sulfonylurea drug, because of concern about teratogenicity and neonatal hypoglycemia. There is little information about the efficacy (...) of these drugs in this group of women. We studied 404 women with singleton pregnancies and gestationaldiabetesthat required treatment. The women were randomly assigned between 11 and 33 weeks of gestation to receive glyburide or insulin according to an intensified treatment protocol. The primary end point was achievement of the desired level of glycemic control. Secondary end points included maternal and neonatal complications. The mean (+/-SD) pretreatment blood glucose concentration as measured at home
Dietary regulation for 'gestationaldiabetes'. BACKGROUND: Impaired glucose metabolism in pregnancy may be associated with adverse pregnancy outcomes. Primary dietary therapy is used in the management of diabetes, including gestationaldiabetes. OBJECTIVES: The objective of this review was to assess the effects of primary dietary therapy in women identified as having gestationaldiabeteson fetal growth and neonatal outcomes. SEARCH STRATEGY: I searched the Cochrane Pregnancy and Childbirth
Managed care does not lower costs but may result in poorer outcomes for patients with gestationaldiabetesManaged care does not lower costs but may result in poorer outcomes for patients with gestationaldiabetesManaged care does not lower costs but may result in poorer outcomes for patients with gestationaldiabetesBienstock J L, Blakemore K J, Wang E, Presser D, Misra D, Pressman E K Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion (...) on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Management of gestationaldiabetes; Female genital diseases and pregnancy complications. Type of intervention Primary prevention and secondary prevention. Economic study type Cost-effectiveness analysis. Study population Patients with diagnosed gestationaldiabetes. Setting Primary
Postprandial versus preprandial blood glucose monitoring in women with gestationaldiabetesmellitus requiring insulin therapy. 7565999 1995 11 09 1995 11 09 2011 11 17 0028-4793 333 19 1995 Nov 09 The New England journal of medicine N. Engl. J. Med. Postprandial versus preprandial blood glucose monitoring in women with gestationaldiabetesmellitus requiring insulin therapy. 1237-41 The fetuses of women with gestationaldiabetesmellitus are at risk for macrosomia and its attendant (...) complications. The best method of achieving euglycemia in these women and reducing morbidity in their infants is not known. We compared the efficacy of postprandial and preprandial monitoring in achieving glycemic control in women with gestationaldiabetes. We studied 66 women with gestationaldiabetesmellitus who required insulin therapy at 30 weeks of gestation or earlier. The women were randomly assigned to have their diabetes managed according to the results of preprandial monitoring or postprandial